hector mesa
Indiana University, Purdue University Indianapolis
Indianapolis, United States
Review Editor
Hematologic Malignancies
- Frontiers in Oncology
- Hematologic Malignancies
- Editorial Board
Type at least 3 characters
774 editors
Shape the future of research in your field
Join the board
Editors
Review Editors
elisabetta metafuni
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Rome, Italy
Review Editor
Hematologic Malignancies
leland metheny
University Hospitals of Cleveland
Cleveland, United States
Review Editor
Hematologic Malignancies
yi miao
Department of Hematology, First Affiliated Hospital, Nanjing Medical University
Nanjing, China
Review Editor
Hematologic Malignancies
kevin charles miller
Memorial Sloan Kettering Cancer Center
New York, United States
Review Editor
Hematologic Malignancies
alice mims
Comprehensive Cancer Center, The Ohio State University
Columbus, United States
Review Editor
Hematologic Malignancies
xiao-dong mo
Peking University People's Hospital
Beijing, China
Review Editor
Hematologic Malignancies
elena beatriz moiraghi
Hospital Ramos Mejía
Buenos Aires, Argentina
Review Editor
Hematologic Malignancies
matteo molica
Haematology Unit, S. Eugenio, Rome
Rome, Italy
Review Editor
Hematologic Malignancies
stefano molica
Hull University Teaching Hospitals NHS Trust
Hull, United Kingdom
Review Editor
Hematologic Malignancies
cusan monica
Medical Clinic and Polyclinic III, LMU Munich University Hospital
Munich, Germany
Review Editor
Hematologic Malignancies
marco montillo
Department of Haematology, Niguarda Ca 'Granda Hospital
Milano, Italy
Review Editor
Hematologic Malignancies
barbara mora
IRCCS Ca 'Granda Foundation Maggiore Policlinico Hospital
Milan, Italy
Review Editor
Hematologic Malignancies
fortunato morabito
Biotechnology Research Unit, Provincial Health Authority of Cosenza
Cosenza, Italy
Review Editor
Hematologic Malignancies
jerome moreaux
Institut de Génétique Humaine, Université de Montpellier
Montpellier, France
Review Editor
Hematologic Malignancies
blake stephen moses
Keros Therapeutics, Inc.
Lexington, United States
Review Editor
Hematologic Malignancies